ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1991

Inhibition of CD44 Intracellular Domain Production Suppresses Bovine Articular Chondrocyte De-differentiation Induced by Excessive Mechanical Stress Loading

Yasumori Sobue1, Nobunori Takahashi 2, Naoki Ishiguro 2 and Toshihisa Kojima 2, 1Nagoya University Graduate School of Medicine, Nagoya, Japan, 2Department of Orthopedic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: cartilage and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Osteoarthritis & Joint Biology – Basic Science Poster

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: CD44 fragmentation is enhanced in chondrocytes of osteoarthritis (OA) patients. Excessive mechanical stress loading is a risk factor for OA, but the molecular mechanism underlying the relationship is unclear. We hypothesized that mechanical stress-induced enhancement of CD44-ICD production plays an important role in the de-differentiation of chondrocytes and OA. This study aimed to assess the relationship between CD44-ICD and chondrocyte gene expression.

Methods: Monolayer cultured primary bovine articular chondrocytes (BACs) were subjected to cyclic tensile strain (CTS) loading using a stretching system (STB-140) at various intensities. An ADAM10 inhibitor (GI254023X) and γ-secretase inhibitor (DAPT) were used to inhibit CD44 cleavage. In overexpression experiments, BACs were electroporated with a plasmid encoding CD44-ICD(pCMV/myc/cyto-CD44ICD).

Results: CTS loading increased the expression of ADAM10 and subsequent CD44 cleavage, while decreasing the expression of SOX9, aggrecan, and type 2 collagen (COL2) in an intensity-dependent manner. Both GI254023X and DAPT reduced the production of CD44-ICD upon CTS loading, and significantly rescued the reduction of SOX9 expression by CTS loading in a dose-dependent manner. Chemical inhibition of CD44-ICD production also rescued aggrecan and COL2 expression following CTS loading.
Induction of chondrocyte de-differentiation by CD44-ICD overexpression
The effect of CD44-ICD overexpression on the expression of chondrogenic differentiation-related genes was also assessed. As shown in Fig. A, two CD44-ICD bands of about 15 kD (a strong band and weak band) were observed in lysates of BACs transfected with the CD44-ICD plasmid by Western blot, while corresponding bands were absent in BACs that were not transfected or were transfected with control plasmid. SOX9 protein expression was reduced in BACs transfected with CD44-ICD, but not in controls (Fig. A). CD44-ICD significantly decreased the mRNA expression of SOX9, aggrecan, and COL2, while increasing the expression of COL1 mRNA (Fig. B). This suggests that the ability to maintain the chondrocyte phenotype was disrupted by CD44-ICD overexpression. These results suggest that CD44-ICD overexpression or CD44-ICD production upon excess mechanical stress loading can promote the de-differentiation of articular chondrocytes.

Conclusion: Our findings suggest that CD44-ICD is closely associated with the de-differentiation of chondrocytes. Excessive mechanical stress loading promoted the de-differentiation of BACs by enhancing CD44 cleavage and CD44-ICD production. Suppression of CD44 cleavage has potential as a novel treatment strategy for OA.

Effect of CD44-ICD overexpression on bovine articular chondrocytes -BACs- de-differentiation.
-A- BACs were transfected with plasmid DNA expressing CD44-ICD -pCMV/myc/cyto-CD44ICD- or empty plasmid as a control using an electroporator -NEPA21-. A strong band of about 15 kD was observed in BACs transfected with the CD44-ICD plasmid, which was consistent with the addition of anti-Myc antibody, and SOX9 levels were reduced in these cells. -B- CD44-ICD overexpression significantly decreased the mRNA expression of chondrocyte differentiation markers -SOX9, aggrecan, and collagen type 2 [COL2]-. In contrast, CD44-ICD overexpression significantly increased the mRNA expression of a chondrocyte de-differentiation marker -collagen type 1 [COL1]-. N = 6, *p < 0.05.


Disclosure: Y. Sobue, None; N. Takahashi, AbbVie, 8, Asahi Kasei, 8, Astellas, 8, Bristol-Myers Squibb, 8, Chugai, 8, Chugai Pharmaceutical CO.,LTD., 8, Daiichi-Sankyo, 8, Eisai, 8, Eli Lilly, 8, Janssen, 8, Mitsubishi Tanabe, 8, Ono, 8, Pfizer, 8, Takeda, 8, UCB Japan, 8; N. Ishiguro, AbbVie, 2, 8, Abbvie, 2, 8, Asahi Kasei, 2, 8, Astellas, 2, 8, Astellas Pharma, 2, 8, Bristol-Myers Squibb, 2, 8, Chugai, 2, 8, Chugai Pahrmaceutical, 2, 8, Chugai Pharmaceutical CO.,LTD., 2, 8, Daiichi-Sankyo, 2, 8, Eisai, 2, 8, Eli Lilly, 2, 8, Janssen Pharmaceutical, 8, Kaken, 2, 8, Lilly, 8, Medical Corporation Sanjinkai, 2, 5, 8, Medical Corporation Toukoukai, 2, 5, 8, Mitsubishi Tanabe, 2, 8, Ono, 2, 8, Otsuka, 2, 8, Pfizer, 2, 8, Taisho Toyama, 2, 8, Takeda, 2, 8, Tanabe Mitsubishi Pharma, 2, 8, UCB, 8, Zimmer Biomet, 2, 8; T. Kojima, AbbVie, 2, 8, Abbvie, 8, Astellas, 2, 8, Bristol-Myers Squibb, 2, 8, Chugai, 2, 8, Chugai Pahrmaceutical, 2, 8, Chugai Pharmaceutical CO., LTD., 2, 8, Daiichi-Sankyo, 2, 8, Eli Lilly, 2, 8, Janssen, 2, 8, Janssen Pharmaceutical, 8, Lilly, 2, 8, Mitsubishi Tanabe, 2, 8, Novartis, 2, 8, Pfizer, 2, 8, Takeda, 2, 8, Tanabe Mitsubishi Pharma, 8.

To cite this abstract in AMA style:

Sobue Y, Takahashi N, Ishiguro N, Kojima T. Inhibition of CD44 Intracellular Domain Production Suppresses Bovine Articular Chondrocyte De-differentiation Induced by Excessive Mechanical Stress Loading [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/inhibition-of-cd44-intracellular-domain-production-suppresses-bovine-articular-chondrocyte-de-differentiation-induced-by-excessive-mechanical-stress-loading/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/inhibition-of-cd44-intracellular-domain-production-suppresses-bovine-articular-chondrocyte-de-differentiation-induced-by-excessive-mechanical-stress-loading/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology